CLDX NASDAQ
Celldex Therapeutics, Inc.
1W: +1.8%
1M: -19.8%
3M: -16.6%
YTD: +17.2%
1Y: +25.1%
3Y: +15.8%
5Y: -42.7%
$31.65
-0.53 (-1.65%)
Weekly Expected Move ±7.9%
$27
$29
$32
$34
$37
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-06-23
Earliest Filing
2024-03-01
Latest Filing
partner: 3
Counterparties (Filed by CLDX)
3 relationshipsCompanies named in CLDX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leerink Partners LLC | — | partner | Underwriter representative for the common stock offering | 2024-03-01 | View |
| Cowen and Company, LLC | — | partner | Underwriter representative for the common stock offering | 2024-03-01 | View |
| Shareholder Representatives Services LLC | — | partner | Settlement agreement regarding previously disclosed litigation arising from the Merger Agreement. | 2022-06-23 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-22 | Other Events; Exhibits | View | |
| 2026-07-15 | Officer/Director Change; Exhibits | View | |
| 2026-06-26 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-04-02 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-06 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-06-14 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2024-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-03-01 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-11-08 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2023-11-06 | Other Events | View | |
| 2023-11-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-08-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR